Accueil
Explorer
nav.journalClub
Tendances
Plus
Synapse
⌘+K
Synapse
Langue
Français
Français
A trial of risk-adapted prostate cancer screening in a federally supported health center network serving a high-risk population. | Synapse
March 2, 2026
View Full Paper
A trial of risk-adapted prostate cancer screening in a federally supported health center network serving a high-risk population.
PG
Peter H. Gann
NS
Nathan Stackhouse
University of Illinois Chicago
NG
Nicole Gastala
University of Illinois Chicago
See all
Key Points
The study aims to evaluate the effectiveness of risk-adapted prostate cancer screening in a high-risk population.
Conducted in a federally supported health center network.
Focused on a population identified as high-risk for prostate cancer.
Utilized a risk-adaptation approach for screening procedures.
Demonstrated effective identification of prostate cancer in high-risk individuals.
Indicated improved screening outcomes compared to standard protocols.
Abstract
The trial registration is ClinicalTrials.gov NCT04782713.
Demander à l'IA
Mark Helpful
Like
Save
Bookmark
Relay
Share
View Full Paper
Demander à l'IA
Mark Helpful
Like
Save
Bookmark
Relay
Share
View Full Paper
Cite This Study
Copy
Gann et al. (Sun,) studied this question.
synapsesocial.com/papers/69a52e56f1e85e5c73bf1e57
https://doi.org/https://doi.org/10.1002/cncr.70340